GlassScriptPhysician profile
Craig D Hametz
NPI 1609053644
$23,092.75
in general payments reported to CMS, 2019-2025
37 companies · $1,568 in 2025
The $1,568 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $6,177 · 2021: $312 · 2022: $906 · 2023: $2,998 · 2024: $876 · 2025: $1,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,744 · Travel and Lodging: $1,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,743.74 |
| Travel and Lodging | $1,697.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $11,424.70 | 2019-2020 | |
| Boston Scientific Corporation | $3,909.67 | 2019-2025 | Watchman Access System, Watchman Flx, Watchman |
| Abbott Laboratories | $2,836.35 | 2019-2025 | Jot Dx, Cardiomems, Mitraclip |
| Janssen Pharmaceuticals, INC | $413.09 | 2019-2021 | |
| Amgen INC. | $405.12 | 2019-2023 | |
| Shockwave Medical, INC | $366.20 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.75 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $317.51 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $305.65 | 2019-2023 | Camzyos |
| Genzyme Corporation | $274.90 | 2019-2025 | |
| Novo Nordisk INC | $250.33 | 2019-2021 | |
| Medtronic, INC. | $248.77 | 2024-2025 | Onyx Frontier |
| Pfizer INC. | $246.43 | 2019-2020 | |
| Edwards Lifesciences Corporation | $210.29 | 2019-2020 | |
| Amarin Pharma, INC. | $204.50 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $192.03 | 2025 | |
| Irhythm Technologies, INC. | $181.66 | 2019-2020 | |
| Abiomed | $143.38 | 2023 | Impella |
| Cook Medical LLC | $114.60 | 2025 | Icast Covered Stent System, 6mmx22mmx120cm |
| Astrazeneca Pharmaceuticals LP | $101.19 | 2019-2020 | |
| Gilead Sciences, INC. | $84.93 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $81.82 | 2019-2020 | |
| Atricure, INC. | $77.59 | 2023 | |
| Esperion Therapeutics, INC. | $61.56 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.66 | 2019-2025 | Lifevest |
| Akcea Therapeutics, INC. | $38.47 | 2019-2020 | |
| Medicomp INC | $37.48 | 2023 | Telepatch Cardiac Monitor |
| Kowa Pharmaceuticals America, INC. | $35.87 | 2019-2020 | |
| Lundbeck LLC | $27.53 | 2019 | |
| Mylan Specialty L.P. | $21.49 | 2020 | |
| Biotronik INC. | $21.24 | 2019 | |
| Medtronic Vascular, INC. | $18.05 | 2019 | |
| Lantheus Medical Imaging, INC. | $17.31 | 2019 | |
| Portola Pharmaceuticals, LLC | $13.82 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.53 | 2019 | |
| Ibsa Pharma INC. | $12.28 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Hametz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.